Generic Review At US FDA: Record Month Completes Approval Volume Recovery
Executive Summary
With 96 full ANDA approvals and 30 tentative approvals, July was the most productive month since GDUFA launched.
You may also be interested in...
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
Gottlieb's 2018 Generic Drug Approval Goal May Be In Doubt
Thanks in large part to new elemental impurities requirements, ANDA approvals are behind the pace needed to beat 2017’s record.